{"id":35165,"date":"2020-11-17T14:53:03","date_gmt":"2020-11-17T14:53:03","guid":{"rendered":"https:\/\/www.biotechpharmasummit.com\/?page_id=35165"},"modified":"2021-03-19T10:42:34","modified_gmt":"2021-03-19T10:42:34","slug":"salvatore-cicirello","status":"publish","type":"page","link":"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/","title":{"rendered":"Salvatore Cicirello"},"content":{"rendered":"<div class=\"vgblk-rw-wrapper limit-wrapper\">\n<h2>Salvatore Cicirello<\/h2>\n<h4>Head of Safety Science &amp; PASS, Global Drug Safety &amp; Risk Management at Bristol Myers Squibb<\/h4>\n\t<p>Salvatore is currently Senior Director, Safety Science and PASS, in Worldwide Patient Safety at BMS.<\/p>\n<p>During his tenure Salvatore has led a wide spectrum of PV activities including PV Innovation, Case Management, Safety Operations and he has also acted as Deputy QPPV.<\/p>\n<p>Salvatore is a Pharmacist by training, he graduated in Chemistry and Pharmaceutical Technologies and holds an MSc in Clinical Research from the University of Florence. Prior to joining Celgene in 2006 he has held different roles in the clinical research area at Parexel, and prior to that in one of the Italian Regional Pharmacovigilance Centers.<\/p>\n<p>&nbsp;<\/p>\n\t\t\t\t\t\t\t<img decoding=\"async\" loading=\"lazy\" src=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile_1.jpg\" alt=\"Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile_1\" itemprop=\"image\" height=\"1224\" width=\"820\" title=\"Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile_1\" onerror=\"this.style.display='none'\" sizes=\"(max-width: 768px) 100vw, 100vw\" srcset=\"data:image\/svg+xml;utf8,<svg%20xmlns=&quot;http:\/\/www.w3.org\/2000\/svg&quot;%20viewBox=&quot;0%200%20820%201224&quot;%20height=&quot;1224px&quot;%20width=&quot;820px&quot;\/>&#8221; data-srcset=&#8221;https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile_1.jpg 820w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile_1-201&#215;300.jpg 201w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile_1-686&#215;1024.jpg 686w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile_1-768&#215;1146.jpg 768w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile_1-630&#215;940.jpg 630w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile_1-420&#215;627.jpg 420w, https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile_1-315&#215;470.jpg 315w&#8221;>\t\t\t\t\t\t\t\n<h3>\n\tTitle: Adoption of Artificial Intelligence in Pharmacovigilance: a framework for the development of cognitive services and the role of the Drug Safety Professional\n\t<\/h3>\n<h4>\n\t\t\t<a href=\"#\" title=\"On the Web\" target=\"_self\" rel=\"noopener noreferrer\">\n\tOn the Web\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.bms.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.bms.com\/<\/a><\/p>\n<h4>\n\t\t\t<a href=\"#\" title=\"On LinkedIn\" target=\"_self\" rel=\"noopener noreferrer\">\n\tOn LinkedIn\n\t\t\t<\/a>\n\t<\/h4>\n\t<p><a href=\"https:\/\/www.linkedin.com\/in\/salvatore-giorgio-cicirello-77a7125\/\" target=\"_blank\" rel=\"noopener noreferrer\">Visit Profile<\/a><\/p>\n<\/div><!-- .vgblk-rw-wrapper -->","protected":false},"excerpt":{"rendered":"<p>Salvatore Cicirello Head of Safety Science &amp; PASS, Global Drug Safety &amp; Risk Management at Bristol Myers Squibb Salvatore is currently Senior Director, Safety Science and PASS, in Worldwide Patient Safety at BMS. During his tenure Salvatore has led a wide spectrum of PV activities including PV Innovation, Case Management, Safety Operations and he has&#8230;<\/p>\n","protected":false},"author":1,"featured_media":35166,"parent":35001,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-35165","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Salvatore Cicirello &#8226; BioTech Pharma Summit<\/title>\n<meta name=\"description\" content=\"Salvatore is currently Senior Director, Safety Science and PASS, in Worldwide Patient Safety at BMS.During his tenure Salvatore has led a wide spectrum of PV activities including PV Innovation, Case Management, Safety Operations and he has also acted as Deputy QPPV.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Salvatore Cicirello &#8226; BioTech Pharma Summit\" \/>\n<meta property=\"og:description\" content=\"Salvatore is currently Senior Director, Safety Science and PASS, in Worldwide Patient Safety at BMS.During his tenure Salvatore has led a wide spectrum of PV activities including PV Innovation, Case Management, Safety Operations and he has also acted as Deputy QPPV.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/\" \/>\n<meta property=\"og:site_name\" content=\"BioTech Pharma Summit\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/biotechpharmasummit\/\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-19T10:42:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"900\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@biotechsummit\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/\",\"name\":\"Salvatore Cicirello &#8226; BioTech Pharma Summit\",\"isPartOf\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile.jpg\",\"datePublished\":\"2020-11-17T14:53:03+00:00\",\"dateModified\":\"2021-03-19T10:42:34+00:00\",\"description\":\"Salvatore is currently Senior Director, Safety Science and PASS, in Worldwide Patient Safety at BMS.During his tenure Salvatore has led a wide spectrum of PV activities including PV Innovation, Case Management, Safety Operations and he has also acted as Deputy QPPV.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/#primaryimage\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile.jpg\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile.jpg\",\"width\":900,\"height\":900},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmacovigilance &#038; Drug Safety 2021 Speakers\",\"item\":\"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Salvatore Cicirello\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#website\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"name\":\"BioTech Pharma Summit\",\"description\":\"The Tomorrow&#039;s healthcare congress\",\"publisher\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#organization\",\"name\":\"EPM Group\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"contentUrl\":\"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png\",\"width\":2000,\"height\":2000,\"caption\":\"EPM Group\"},\"image\":{\"@id\":\"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/biotechpharmasummit\/\",\"https:\/\/x.com\/biotechsummit\",\"https:\/\/www.instagram.com\/biotechpharmasummit\/\",\"https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Salvatore Cicirello &#8226; BioTech Pharma Summit","description":"Salvatore is currently Senior Director, Safety Science and PASS, in Worldwide Patient Safety at BMS.During his tenure Salvatore has led a wide spectrum of PV activities including PV Innovation, Case Management, Safety Operations and he has also acted as Deputy QPPV.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/","og_locale":"en_US","og_type":"article","og_title":"Salvatore Cicirello &#8226; BioTech Pharma Summit","og_description":"Salvatore is currently Senior Director, Safety Science and PASS, in Worldwide Patient Safety at BMS.During his tenure Salvatore has led a wide spectrum of PV activities including PV Innovation, Case Management, Safety Operations and he has also acted as Deputy QPPV.","og_url":"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/","og_site_name":"BioTech Pharma Summit","article_publisher":"https:\/\/www.facebook.com\/biotechpharmasummit\/","article_modified_time":"2021-03-19T10:42:34+00:00","og_image":[{"width":900,"height":900,"url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@biotechsummit","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/","url":"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/","name":"Salvatore Cicirello &#8226; BioTech Pharma Summit","isPartOf":{"@id":"https:\/\/www.biotechpharmasummit.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/#primaryimage"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/#primaryimage"},"thumbnailUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile.jpg","datePublished":"2020-11-17T14:53:03+00:00","dateModified":"2021-03-19T10:42:34+00:00","description":"Salvatore is currently Senior Director, Safety Science and PASS, in Worldwide Patient Safety at BMS.During his tenure Salvatore has led a wide spectrum of PV activities including PV Innovation, Case Management, Safety Operations and he has also acted as Deputy QPPV.","breadcrumb":{"@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/#primaryimage","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile.jpg","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/11\/Salvatore_Cicirello_BMS_BioTech_Pharma_Summit_2021_Profile.jpg","width":900,"height":900},{"@type":"BreadcrumbList","@id":"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/salvatore-cicirello\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.biotechpharmasummit.com\/"},{"@type":"ListItem","position":2,"name":"Pharmacovigilance &#038; Drug Safety 2021 Speakers","item":"https:\/\/www.biotechpharmasummit.com\/index.php\/pharmacovigilance-drug-safety-2021-speakers\/"},{"@type":"ListItem","position":3,"name":"Salvatore Cicirello"}]},{"@type":"WebSite","@id":"https:\/\/www.biotechpharmasummit.com\/#website","url":"https:\/\/www.biotechpharmasummit.com\/","name":"BioTech Pharma Summit","description":"The Tomorrow&#039;s healthcare congress","publisher":{"@id":"https:\/\/www.biotechpharmasummit.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.biotechpharmasummit.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.biotechpharmasummit.com\/#organization","name":"EPM Group","url":"https:\/\/www.biotechpharmasummit.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","contentUrl":"https:\/\/www.biotechpharmasummit.com\/wp-content\/uploads\/2020\/05\/B_2_Logo_BioTech_Pharma_Summit_Porto.png","width":2000,"height":2000,"caption":"EPM Group"},"image":{"@id":"https:\/\/www.biotechpharmasummit.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/biotechpharmasummit\/","https:\/\/x.com\/biotechsummit","https:\/\/www.instagram.com\/biotechpharmasummit\/","https:\/\/www.linkedin.com\/company\/biotech-pharma-summit\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/35165","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/comments?post=35165"}],"version-history":[{"count":4,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/35165\/revisions"}],"predecessor-version":[{"id":36221,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/35165\/revisions\/36221"}],"up":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/pages\/35001"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media\/35166"}],"wp:attachment":[{"href":"https:\/\/www.biotechpharmasummit.com\/index.php\/wp-json\/wp\/v2\/media?parent=35165"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}